Retatrutide10mg 15mg 20mg 30mg Top Fat Burning Peptides

Retatrutide (retatrutide/retatrutide) is an innovative therapeutic drug. The following is a detailed introduction to it:

English name: Retatrutide
Article Title: Retarglutide/Rataglutide
CAS number: 2381089-83-2
Drug type: glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide 1 (GLP-1)/glucagon (GCG) triple receptor agonist

Mechanism of action

Retatrutide exerts multiple regulatory effects by simultaneously activating three receptors: GIP, GLP-1 and GCG:
Regulate blood sugar: Improve glucose tolerance and help patients with type 2 diabetes lower blood sugar.
Slows gastric emptying: By acting on the gastrointestinal tract, it slows down the passage of food through the digestive tract.
Reduces appetite: Acts on receptors in the brain to reduce people's desire for food, thereby aiding weight loss.

Clinical trial results

Weight loss effect: In phase 2 clinical trials, Retatrutide demonstrated significant weight loss effects. Obese patients lost more than 24% of their body weight after 48 weeks of treatment with Retatrutide. Among them, patients taking 8mg and 12mg doses lost at least 5% of their weight, and the weight loss effect of the high-dose group (12mg) was more significant.
Hypoglycemic effect: After 6 months of treatment with different doses of Retatrutide in patients with type 2 diabetes, glycated hemoglobin (HbA1c) decreased by 1.3%\~2.0%.
Safety: The safety and tolerability profile of Retatrutide is similar to other receptor agonists. The most common adverse reactions are gastrointestinal reactions, such as nausea, diarrhea, vomiting and constipation, mostly mild to moderate. In addition, some patients experience symptoms of increased heart rate, but this usually resolves after 24 weeks.

Scope of application
Obesity treatment: As an auxiliary treatment to diet control and exercise, it is used for long-term weight management in adults who are obese or overweight and have at least one weight-related comorbidity.
Type 2 diabetes treatment: Helps patients with type 2 diabetes lower blood sugar and lose weight at the same time.

  Product packaging

5mg/vial,10vials/box;

10mg/vial,10vials/box;

15mg/vial,10vials/box;

60mg/vial,10vials/box;

Company Profile

 The company was established in recent years and is committed to applying advanced biotechnology to the health industry to meet the market's demand for high-quality, high-efficiency peptide products.
As a leading peptide manufacturer,Zhiwen Technology has a R&D team composed of senior scientists and engineers, which continues to explore and innovate, and is committed to developing safer, more effective, and more market-competitive peptide products. The company's main products cover but are not limited to pharmaceutical grade, food grade and cosmetic grade and other fields, and are widely used in many aspects such as health care, disease prevention, beauty and skin care.

In terms of production technology, Zhiwen Technology adopts internationally advanced production equipment and technology to ensure that every aspect of the product, from raw material selection, production and processing to finished product packaging, strictly follows relevant national standards and specifications to ensure product quality and safety. At the same time, the company has also established a complete quality management system and after-sales service system to provide customers with all-round, one-stop service support.
Zhiwen Technology adheres to the corporate philosophy of "technology leads health, quality creates the future" and always adheres to the development path of people-oriented and technological innovation. The company not only focuses on product quality and innovation, but also actively fulfills its social responsibilities and is committed to promoting the development and progress of the health industry.